Drug companies are required to file information about the testing of their new drugs with the Food & Drug Administration. These are called IND filings. AIDS-related IND filings are sometimes available from the FDA's FOIA office (301-443-1813). Other INDs generally are not. Information considered a "trade secret" never is.